BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P3D
REFRESH-INTERVAL:P3D
CALSCALE:GREGORIAN
BEGIN:VEVENT
DTSTART:20190131T163000Z
DTEND:20190131T183000Z
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
SUMMARY:NCBIO Life Science Forum - Reshaping How We Treat Disease January 2019
DESCRIPTION:We have added an overflow room to accommodate additional registrants. Please note that seating in the main room will be on a first come first serve basis. If more than 2-3 are registered from a single organization\, please have additional colleagues use the overflow room.\n\n\n\nThere are several new therapies that are reshaping the way we treat disease. Come hear leaders discuss their cutting-edge technologies in gene therapy\, cell therapy\, gene editing\, and nanotechnology. Speakers will discuss how these therapies work\, what companies need to succeed\, and pricing/reimbursement models. Confirmed speakers include:\n\n Michael Dombeck\, Vice President of Business Development\, Precision BioSciences\n Tom Jede\, Site Head and Senior Director\, Vector Manufacturing\, bluebird bio\n Susan Nichols\, Chief Executive Officer\, Falcon Therapeutics\n Alden Pritchard\, Chief Executive Officer\, Kaio Therapy\n Moderator to be added.\n\nThank you to our sponsors: Aperio Clinical Outcomes\, BIO\, Hughes Pittman & Gupton\, and Smith Anderson.
X-ALT-DESC;FMTTYPE=text/html:We have added an overflow room to accommodate additional registrants. Please note that seating in the main room will be on a first come first serve basis. If more than 2-3 are registered from a single organization\, please have additional colleagues use the overflow room.
\n
\nThere are several new therapies that are reshaping the way we treat disease. Come hear leaders discuss their cutting-edge technologies in gene therapy\, cell therapy\, gene editing\, and nanotechnology. Speakers will discuss how these therapies work\, what companies need to succeed\, and pricing/reimbursement models. Confirmed speakers include:\n